Transcript The STS – CCAS Database Update

David F. Vener, M.D.
Database Coordinator
Congenital Cardiac Anesthesia Society
Assoc. Professor of Pediatrics and Anesthesiology
Baylor College of Medicine/Texas Childrens Hospital
Houston, TX
Disclaimer Slide
 I am not associated with any commercial vendors,
ventures or products associated with the creation or
maintenance of the STS Congenital Heart Database or
the CCAS and do not receive funds from any
commercial vendors, the STS or the CCAS for my work.
I have no known conflicts of interest to disclose in
relationship to this talk.
CCAS Database Committee
 Nina Guzzetta, MD – Emory University/CHCA
 Jumbo Williams, MB - Stanford
 Lena Sun, MD – Columbia University, NYC
 Mark Twite, MD – Denver Children’s
 Anshuman Sharma, MD – Washington Univ St Louis
 Courtney Hardy, MD – Children’s Memorial, Chicago
 David Jobes, MD – CHOP
 Roxann Barnes, MD – Mayo Clinic
 Scott Schulman, MD – Duke
Background
 Anesthesia-related complications are relatively rare
events and congenital cardiac surgery is a relatively
rare procedure so the only way to contemporaneously
and accurately capture anesthesia-related data is
through a multi-site model.
 Patients with congenital heart disease have up to 85x
greater likelihood of having an adverse event
intraoperatively than non-cardiac patients, regardless
of the procedure being performed.
Participation
 Data start date of January 1, 2010
 Current fee schedule: $3500 per year, regardless of
number of anesthesia providers or cases. This does
not include any expenses associated with vendor fees
and is in addition to any fees paid by the congenital
heart surgeons.
 Cases input into database may include not only cardiac
surgical cases, but any procedures in which congenital
cardiac anesthesiologists are involved: Cath Lab,
Diagnostic and Interventional Radiology, General OR,
ICU, etc.
Results
 On August 1, 2011 we received back the first report
from the STS-CCAS data collection efforts
 20 Programs paid the $3500 fee, of which 18 submitted
at least some minimal data to DCRI during the Spring
2011 harvest for calendar year 2010
 The results represent both full and partial calendar
year submissions and many centers chose to enter only
CV surgical cases at this time.
Who submitted?
2010 Annual Volume Categories, CPB Cases
(Provided Groupings)
Volume
 Small (< 125)
 Medium (125 – 250)
 Large (251 – 500)
 Very Large (> 500)
Number of Participants
6
7
3
2
Who submitted?
Number of Participants by the 4 US Census Regions
Region
 Midwest
 Northeast
 South
 West
Number of Participants
2
4
8
4
Case Types
 Total of 5,757 anesthesia cases submitted




Surgical
 CPB – 3,386 (58.8%)
 No CPB – 1,084 (18.8%)
Cardiology – 772 (13.4%)
 Diagnostic – 44 (0.8%)
 Interventional – 474 (8.2%)
 Electrophysiology Studies/Tx – 254 (4.4%)
Support Devices (VAD, ECMO) – 146 (2.5%)
Other (Thoracic, Minor, etc.) – 369 (6.4%)
Age of Patients Submitted 2010
STS – EACTS Mortality/Complexity
Categories
*Not Assigned includes all non-CV surgical cases.
Overall Adverse/Unexpected Events
 None/Missing – 5,589 (97.1%)
 Airway






Dental - 3 (0.1%)
Respiratory Arrest – 2 (0.0%)
Unexpected Difficult Intubation – 23 (0.4%)
Stridor – 18 (0.3%)
Unexpected Extubation – 3 (0.1%)
Airway injury – 1 (0.0%)
Overall Adverse/Unexpected Events
 Vascular Injury/Line Related
 Arrhythmia requiring Tx with CVL – 1 (0.0%)
 Myocardial Injury with CVL – 1 (0.0%)
 Vascular Injury w CVL (Bleeding) – 15 (0.3%)
 Vascular Access Issues (unable to obtain desired access
within one hour of induction) – 46 (0.8%)
 Hematoma – 3 (0.1%)
 Inadvertent Arterial Puncture – 32 (0.6%)
 Regional Anesthesia-Related – 1 (0.0%) bleeding @
site
Overall Adverse/Unexpected Events
 Drug-Related Events
 Anaphylaxis/Anaphylactoid Reaction - 6 (0.1%)
 Medication Administration (Wrong Drug) – 1
(0.0%)
 Medication Dosage – 2 (0.0%)
 Suspected Malignant Hyperthermia – 1 (0.0%)
 Protamine Reaction req Tx – 3 (0.1%)
 Cardiac Arrest Unrelated to Surgery – 10 (0.2%)
 (compared to Odegard et al: 11/5213 (0.2%))
Overall Adverse/Unexpected Events
 TEE – Related
 Esophageal Bleeding/Rupture – 3 (0.1%)
 Extubation – 1 (0.0%)
 Airway Compromise w TEE – 11 (0.2%)
 Patient Transfer Events – 2 (0.0%)
 Neurologic Injury – 4 (0.1%)
Pre-Operative Medications (Surgical
Cases Only)
 Anticoagulants – 382 (8.5%)
 Antiarrhythmics – 108 (2.4%)
 Prostaglandin – 383 (8.6%)
 Cardiac Medications
 IV Inotropes – 368 (8.2%)
 IV Systemic Vasodilators – 30 (0.7%)
 IV Systemic Vasoconstrictors – 30 (0.4%)
 IV Pulmonary Vasodilators – 1 (0.0%)
Neurologic Monitoring (Surgical
Cases Only)
 Yes - 2713 (60.7%)
 Of those monitored there is an analysis problem with
this in that it allowed single-choice only, where multimodal monitoring is used frequently:
 NIRS 2449 (90.3%)
 TCD 5 (0.2%)
 BIS 233 (8.6%)
 Other 4 (0.1%) – other forms of EEG?
Areas for Improvement
 Report Writing
 There were multiple areas where the report produced did not
really match up what we were trying to ascertain. This is largely
a formatting issue that can be easily addressed.
 New Items
 Updated drug listings
 Updated complications
 Better information about airway issues (preoperative FiO2, in-
situ airways, airway intubation mechanism (DL, FOB, etc.)
Areas for Improvement
 Ultrasound Guidance for CVL placement
 New Dispositions
 Discharge Home as planned
 Admit to Floor as planned
 Admit to ICU as planned
 Unexpected admission to hospital or ICU
 Perioperative Demise (within 24 hours of last
anesthetic), regardless of cause
Contact Information
 The collection of anesthesia fields will be associated
with a number of questions. I am always available by
email to answer any questions. Please do not hesitate
to contact me:
[email protected]
David Vener, MD
Departments of Pediatrics and Anesthesiology
Baylor College of Medicine
Houston, TX